Live Breaking News & Updates on Novaccess Global Inc View

Stay updated with breaking news from Novaccess global inc view. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

NovAccess Global Inc.: Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award

Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon AwardCLEVELAND, OH / ACCESSWIRE / March 15, 2023 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing ....

United States , Santa Cruz Division , Dennis Riedl , Dwain Irvin , Los Angeles , Christopher Wheeler , University Of California , Securities Exchange Commission , Department Of Chemistry Biochemistry , Darrow Associates , World Orphan Drug Congress , Novaccess Global Inc View , World Brain Mapping Foundation , Vaccine Manufacturing Laboratory , World Brain Mapping Foundation Annual Congress , Sinai Medical Center Department Of Neurosurgery , Society For Brain Mapping , Securities Exchange , Our Company , Novaccess Global Inc , Stemvax Therapeutics Inc , Novaccess Lead Scientist , Receives Prestigious Golden Axon , Novaccess Global , Golden Axon Award , Annual Congress ,

NovAccess Global Inc.: NovAccess Global to Present at World Orphan Drug Congress

CLEVELAND, OH / ACCESSWIRE / February 16, 2023 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced that its CEO Dr. Dwain ....

United States , Dennis Riedl , Dwain Irvin , Christopher Wheeler , Securities Exchange Commission , Darrow Associates , Drug Administration , World Orphan Drug Congress , Novaccess Global Inc View , Securities Exchange , Office Of Orphan Products Development , Our Company , Stemvax Therapeutics Inc , Novaccess Global Inc , Novaccess Global , Access Global , Orphan Drug Designation , Novacess Global , Orphan Products Development , Orphan Drug , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Relations Contact ,

NovAccess Global Inc.: NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress

Dr. Christopher Wheeler, NovAccess Lead Scientist, to Receive Leadership Award for his ContributionsCLEVELAND, OH / ACCESSWIRE / February 3, 2023 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company ....

United States , Santa Cruz Division , Dwain Irvin , Los Angeles , Schwierige Zeiten , Christopher Wheeler , University Of California , Securities Exchange Commission , Department Of Chemistry Biochemistry , Darrow Associates , Novaccess Global Inc View , World Brain Mapping Foundation , Vaccine Manufacturing Laboratory , World Brain Mapping Foundation Annual Congress , Society For Brain Mapping Therapeutics , Sinai Medical Center Department Of Neurosurgery , Society For Brain Mapping , Securities Exchange , Our Company , Novaccess Global Inc , Stemvax Therapeutics Inc , Novaccess Lead Scientist , Receive Leadership Award , Novaccess Global , Tie Gala , Brain Mapping ,

NovAccess Global Inc.: NovAccess Global Announces Fireside Chat with Dr. Christopher Wheeler, the Company's Lead Scientist and President of its StemVax Therapeutics Division

Topic: Immunotherapy Advantages Over Surgical TreatmentCLEVELAND, OH / ACCESSWIRE / January 5, 2023 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain ....

Cori Freeman , Dwain Irvin , J Kyle Moyer , Christopher Wheeler , Securities Exchange Commission , Company Board Of Directors , Darrow Associates , Drug Administration , Novaccess Global Inc View , Vaccine Manufacturing Laboratory , Securities Exchange , Sinai Medical Center Department Of Neurosurgery , Our Company , Stemvax Therapeutics Inc , Novaccess Global Inc , Novaccess Global , Biotech Novelty , Investigational New Drug , Stemvax Therapeutics , Orphan Drug Designation , Cedars Sinai Medical Center Department , Operations Director , Precision Medicine Initiative , Brain Tumors , Institutional Animal Care , Use Committee ,

NovAccess Global Inc.: NovAccess Global Announces Initial Fireside Chat with Glioblastoma Patient Advocate

Topic: Benefits of Immunotherapies Versus Conventional Chemotherapy for Patients and Their Support NetworksCLEVELAND, OH / ACCESSWIRE / November 22, 2022 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical ....

Cori Freeman , Dwain Irvin , Christopher Wheeler , Securities Exchange Commission , Company Board Of Directors , Darrow Associates , Novaccess Global Inc View , Their Support Networks , Securities Exchange , Our Company , Stemvax Therapeutics Inc , Novaccess Global Inc , Their Support , Novaccess Global , Access Global , Orphan Drug , Access Global Fireside Chat Series Schedule , Access Global Board Member Perspectives , Biomedical Field , Select Executive , Advantages Over Surgical , Brian Tumor , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Relations Contact ,